Head-to-head
HealthRX vs Enhance MD
Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. HealthRX is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
HealthRX is $209 a month all-in for tirzepatide; Enhance MD is $280. Over twelve months that is $2,148 against $3,360. Value Scores are 82.1 and 57.8 out of 100.
Tirzepatide
Plan pages: HealthRX plans · Enhance MD plans
At 10 mg/week, HealthRX is $209 a month all-in and Enhance MD is $280 — $71 apart, or $852 across a year. Over twelve months the totals are $2,148 (prepaid term) and $3,360 (billed monthly).
HealthRX charges a flat $209 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Enhance MD prices tirzepatide by dose: $169 per month at 2.5 mg rising to $280 at 10 mg, a difference of $111 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | HealthRX | Rank | Enhance MD | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $209 | 11/31 | $169 | 2/31 | Enhance MD by $40 |
| 5 mg | $209 | 5/17 | — | — | only HealthRX publishes |
| 7.5 mg | $209 | 5/17 | — | — | only HealthRX publishes |
| 10 mg | $209 | 5/27 | $280 | 9/27 | HealthRX by $71 |
| 12.5 mg | $209 | 5/17 | — | — | only HealthRX publishes |
| 15 mg | $209 | 5/17 | — | — | only HealthRX publishes |
The lead changes with the dose. Between 2.5 mg and 10 mg it passes to HealthRX. Pick on the dose you expect to settle at, not the headline.
Across the 27 programs this database can rank on tirzepatide, HealthRX sits 5 of 27 on all-in monthly cost and Enhance MD sits 7. There is 1 other program priced between them. The field median is $339 and the floor is $169, so both sit below the median. HealthRX is $40 above the cheapest tirzepatide program on record. Enhance MD is $111 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — HealthRX undercuts it by $240, Enhance MD by $169. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | HealthRX | Enhance MD | Cheaper |
|---|---|---|---|
| Month to month | — | $280 | only Enhance MD publishes this term |
| 3-month term | $209 | — | only HealthRX publishes this term |
| 12-month term | $179 | — | only HealthRX publishes this term |
| Settled dose | HealthRX | Enhance MD | Difference |
|---|---|---|---|
| 2.5 mg | $2,508 | $2,028 | $480 apart |
| 5 mg | $2,508 | — | one side unpriced |
| 7.5 mg | $2,508 | — | one side unpriced |
| 10 mg | $2,508 | $3,360 | $852 apart |
| 12.5 mg | $2,508 | — | one side unpriced |
| 15 mg | $2,508 | — | one side unpriced |
HealthRX publishes no rate for month to month, 6-month term; Enhance MD publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $2,508 on HealthRX and $3,249 on Enhance MD — $741 apart, and a different gap from the $852 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Enhance MD publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 82.1 for HealthRX and 57.8 for Enhance MD, against a tirzepatide category floor of $169. HealthRX leads by 24.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| HealthRX | 56.6 | 10.5 | 10 | 5 | 82.1 |
| Enhance MD | 42.2 | 10.5 | 0 | 5 | 57.8 |
Semaglutide
Plan pages: HealthRX plans · Enhance MD plans
At 2.4 mg/week, HealthRX is $133 a month all-in and Enhance MD is $212 — $79 apart, or $948 across a year. Over twelve months the totals are $1,188 (prepaid term) and $2,544 (billed monthly).
HealthRX charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Enhance MD charges a flat $212 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
HealthRX is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 93.4 for HealthRX and 58.1 for Enhance MD, against a semaglutide category floor of $129. HealthRX leads by 35.3 points, driven mostly by price.
Where the two programs differ
All-in monthly
HealthRX is cheaper month to month — $209 against $280, a gap of $71 every month, or $852 across a year if both rates hold.
Cancellation terms
Cancellation differs: HealthRX states Per provider terms; confirm at enrollment, while Enhance MD states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
HealthRX asks for 12-month or 3-month plans only; no month-to-month rate published; Enhance MD asks for Monthly, with a first-month discount on GLP-1 Core ($112 first month). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
HealthRX charges one price at every dose; Enhance MD prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Twelve-month cost
Over twelve months the totals are $2,148 for HealthRX and $3,360 for Enhance MD. HealthRX is lower by $1,212 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
HealthRX Official site
HealthRX offers flat per-dose compounded GLP-1 pricing on 12-month and 3-month commitment plans. Its $99/mo semaglutide and $179/mo tirzepatide on the twelve-month plan rank among the lowest annualized figures in the market. No month-to-month rate is published.
It does not publicly name its compounding pharmacy; the record shows healthrx.com (pharmacy partner not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are 12-month or 3-month plans only; no month-to-month rate published; cancellation is Per provider terms; confirm at enrollment; availability is stated as Confirm availability at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture verified 2026-07-18 on healthrx.com
Watch: HealthRX publishes no month-to-month rate; the $99/mo sema and $179/mo tirz are 12-month plan rates. The lowest commitment available is the 3-month plan ($133 sema, $209 tirz). Reported status — RangeYourself verified 2026-07-18 on healthrx.com; our independent checkout is pending.
Enhance MD Official site
Enhance MD bundles GLP-1 medication inside a broader metabolic program including NAD+ coaching, lab testing every six months, and ongoing provider care. The price reflects the full metabolic bundle, not the GLP-1 alone; this makes Enhance MD's figures the least comparable in the database.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, with a first-month discount on GLP-1 Core ($112 first month); cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Enhance MD verified 2026-07-14; price reflects metabolic bundle, not GLP-1 alone
Watch: Figures reflect the bundled metabolic program price, not GLP-1 medication alone. Comparing Enhance MD's $212–$322 to medication-only programs overstates the GLP-1 cost while understating the breadth of service included. The $169 microdosing figure is the most medication-proximate but involves a different dosing protocol. Reported — RangeYourself 2026-07-14.
What neither record tells you
HealthRX does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm availability at intake
- no specific cancellation or refund terms
Enhance MD does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask HealthRX and Enhance MD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. HealthRX, Enhance MD carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. HealthRX publishes a twelve-month rate of $179 a month against $209 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, HealthRX Official site wins this matchup. If you expect to titrate to the top of the ladder, healthrx's flat pricing is worth more than the headline gap suggests.
Both figures should be checked at the provider's own checkout before you pay. HealthRX's tirzepatide price is reported as of 2026-07-18; Enhance MD's is reported as of 2026-07-14.
Questions
Is HealthRX or Enhance MD cheaper for tirzepatide?
HealthRX is cheaper on all-in monthly cost at 10 mg/week: $209 against $280, a difference of $71 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of HealthRX versus Enhance MD?
HealthRX works out to $2,148 across twelve months and Enhance MD to $3,360, on the plan terms each publishes.
Does HealthRX or Enhance MD raise the price as the dose goes up?
HealthRX: no, it charges one flat rate at every dose. Enhance MD: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do HealthRX and Enhance MD differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of HealthRX and Enhance MD names its pharmacy?
Neither. HealthRX records healthrx.com (pharmacy partner not publicly named) and Enhance MD records Partner 503A pharmacy (not named). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the HealthRX and Enhance MD prices?
HealthRX's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-07-18. Enhance MD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
HealthRX, at $133 a month all-in against $212 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: HealthRX official site · Enhance MD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.